Ohio Public Employees Retirement System (OPERS)’s Arbutus Biopharma ABUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-39,000
Closed -$74K 1964
2022
Q3
$74K Buy
+39,000
New +$91.8K ﹤0.01% 1748
2015
Q2
Sell
-5,600
Closed -$98K 1767
2015
Q1
$98K Buy
+5,600
New +$115K ﹤0.01% 1611

Other funds holding ABUS

Ohio Public Employees Retirement System (OPERS)'s ABUS Position: Q4 2022 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Arbutus Biopharma (ABUS) in Q4 2022, closing a stake of 39,000 shares — an estimated $74K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in ABUS in Q1 2015 and held it in 2 quarters. The position peaked at $98K in Q1 2015. 114 funds tracked by Wall St. Rank hold ABUS as of Q4 2022.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining Arbutus Biopharma position as of Q4 2022 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 39,000 Arbutus Biopharma shares in Q4 2022, an estimated $74K.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Arbutus Biopharma in Q1 2015 and held it in 2 quarters.
  • Ohio Public Employees Retirement System (OPERS)'s Arbutus Biopharma position peaked at $98K in Q1 2015.
  • 114 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q4 2022.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q4 2022, filed 15 Feb 2023.